Despite the increasing demand for Real World Evidence (RWE) generation across a product’s lifecycle, there are challenges that need to be carefully addressed. These include the choice of the appropriate data sources and methodological approaches to structure and analyze such data to produce viable action plans.
During the webinar, learn how to effectively address these challenges. Using actual case studies, viewers will understand the development of an effective strategy that incorporates epidemiology, health economics and outcome research, and uses already available Real World data. When such data are not available, learn how to develop the data to support an effective evidence generation plan.
Alex Exuzides, PhD, Director, Health Economics & Epidemiology, ICON Commercialisation & Outcomes
Alex has over 21 years of experience in the application of advanced statistical methods in medicine, health services, health economics, comparative effectiveness research, epidemiology, program evaluation, and risk assessment. His experience includes projects with complex and novel methodological approaches in retrospective database analyses, observational studies, efficacy and safety studies, patient-reported outcomes, pharmacoeconomic, and epidemiological research. Prior to ICON, he was Director of Clinical Outcomes for a leading disease management company, where he was the primary liaison to research partnerships, providing analytical evaluation of new products and program performance focused on diabetes, cardiovascular disease, asthma/COPD, nephrology, and oncology. He is based in San Francisco, with frequent tenures to NYC.Message Presenter
Who Should Attend?
Senior level professionals from biopharmaceutical companies working within:
- Health Economic Outcomes Research (HEOR)
- Comparative Effectiveness/Research
- Clinical Data
ICON’s Commercialisation & Outcomes practices provide insights to clients on strategies and execution for long-term value through customised engagements that fit the compound, the company and the market, maximising products’ success and their benefits to patients’ health.